Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
An early pioneer in oncology CGT, ICON has contributed to over 60 FDA/EMA approved therapies in the last 5 years.
ICON's therapeutic experts contribute regularly to industry publications on the latest medical, scientific and clinical developments.
Plotting a course to bring APAC-developed drugs to the world
Strategies for clinical readiness on day one
Strategies for adapting and achieving optimal market access
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
29 May - 2 June 2026, Booth #35093
Watch the webinar.
ICON Cares is our commitment to making a positive impact on our people, environment and our community.
Delivering successful outcomes across the clinical development lifecycle.
ICON boosts early phase trials with new San Antonio facility, enhancing participant care and operational efficiency.
